ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer

2018 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer​
Villalobos, M.; Czapiewski, P.; Reinmuth, N.; Fischer, J. R.; Andreas, S. ; Kortsik, C. & Serke, M. et al.​ (2018) 
Medical Oncology35(7).​ DOI: https://doi.org/10.1007/s12032-018-1169-5 

Documents & Media

License

GRO License GRO License

Details

Authors
Villalobos, Matthias; Czapiewski, Piotr; Reinmuth, Niels; Fischer, Jürgen R.; Andreas, Stefan ; Kortsik, Cornelius; Serke, Monika; Wolf, Martin; Neuser, Petra; Reuss, Alexander; Schnabel, Philipp A.; Thomas, Michael 
Issue Date
2018
Journal
Medical Oncology 
ISSN
1357-0560
eISSN
1559-131X
Language
English

Reference

Citations


Social Media